Literature DB >> 7245038

Transaxillary sympathectomy (T2 to T4) for relief of vasospastic/sympathetic pain of upper extremities.

R Berguer, R Smit.   

Abstract

Experience with 22 consecutive thoracic sympathectomies is presented. Diagnoses included minor causalgia (12), mixed vasospastic and occlusive disease (4), Raynaud's disease (4), and frostbite with ulceration (2). The operation was a transaxillary resection of ganglia T2, T3, and T4. Both objective and subjective results indicate that this type of sympathectomy is as good as more extensive resections without the risk of a Horner's syndrome. Morbidity was minor but frequent and included dysesthesia, pneumothorax, and compensatory sweating. The success rate of 77%.

Entities:  

Mesh:

Year:  1981        PMID: 7245038

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Efficacy of thoracic sympathetic ganglion block and prediction of complications: clinical evaluation of the anterior paratracheal and posterior paravertebral approaches in 234 patients.

Authors:  K Ohseto
Journal:  J Anesth       Date:  1992-07       Impact factor: 2.078

2.  Alteration in cardiovascular function and body surface temperature during percutaneous stereotactic upper thoracic ganglionectomy and sympathectomy in palmar hyperhidrotic patients.

Authors:  King-Shun Chuang; Wan-Cherng Liu; Jiang-Chuan Liu
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

3.  A new method of thoracoscopic sympathectomy in hyperhidrosis palmaris.

Authors:  C C Lin
Journal:  Surg Endosc       Date:  1990       Impact factor: 4.584

4.  Thoracoscopic sympathectomy for palmar and axillary hyperhidrosis: four-year outcome and quality of life after bilateral 5-mm dual port approach.

Authors:  Kai Bachmann; Nicola Standl; Jussuf Kaifi; Phillip Busch; Eva Winkler; Oliver Mann; Jakob R Izbicki; Tim Strate
Journal:  Surg Endosc       Date:  2009-03-04       Impact factor: 4.584

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.